Morbidity and mortality after neoadjuvant therapy and sleeve lobectomyin N2-disease
Background and objective Sleeve resections were introduced to preserve lung function in patients with limited pulmonary reserve. Increasing experience with sleeve resection has reduced the rate of pneumonectomy below 10%. The aim of the study was to assess the outcome after neoadjuvant chemo- or che...
Main Authors: | Corinna LUDWIG, Walburga ENGEL-RIEDEL, Erich STOELBEN |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2008-10-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://www.lungca.org/index.php?journal=01&page=article&op=view&path%5B%5D=10.3779%2Fj.issn.1009-3419.2008.05.021&path%5B%5D=153 |
Similar Items
-
Endoscopic ultrasound in the pre-therapeutic staging of gastroesophageal adenocarcinoma: the diagnostic value in defining patients eligible for a neoadjuvant chemotherapy regimen
by: Wilko Staiger, et al.
Published: (2010-03-01) -
MRI evaluation of vesical imaging reporting and data system for bladder cancer after neoadjuvant chemotherapy
by: Xinxin Zhang, et al.
Published: (2024-04-01) -
The value of mediastinoscopy in the staging of lung cancer with clinical N2 disease
by: Hui ZHAO, et al.
Published: (2008-10-01) -
N2 disease in non-small cell lung cancer patients, diagnosis and evaluation: a Turkish chest surgeon's perspective
by: Alper TOKER
Published: (2008-10-01) -
Progress of Postoperative Adjuvant Chemotherapy in Stage I Non-small Cell Lung Cancer
by: Bo LIU, et al.
Published: (2015-06-01)